Income Statement Daiho Corporation

Stocks

1822

JP3498600000

Construction & Engineering

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-07-10 EDT			5-day change	1st Jan Change
820.00 ^JPY	-0.24%		+6.08%	+4.46%

05-28	Murakami-linked shareholders cut stake in Daiho Corp to 8.65% from 13.41%, filing shows	RE
05-21	Daiho Corporation's Equity Buyback announced on May 20, 2026, has closed with 4,048,500 shares, representing 4.59% for ¥2,999.94 million.	CI

b6.YfoLAcQ6_g8V-gDjKbdQA0rjvNSn498Pcp3clbVUPp4.PrNkRKAPl3x2iWOzZ9ZpZi2G1qLItbR6Ade33vYCdd8CzGJ5nXSSX3aUOA

Published financial data: DAIHO CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	157B	156B	163B	143B	140B
Total Revenues	157B	156B	163B	143B	140B
Cost of Goods Sold, Total	141B	144B	156B	130B	125B
Gross Profit	15.19B	12B	7.61B	13.14B	15.16B
Selling General & Admin Expenses, Total	6.33B	6.93B	7.14B	7.59B	8.23B
Provision for Bad Debts	2M	-1M	164M	-169M	208M
Other Operating Expenses	-	-	-	12M	35M
Other Operating Expenses, Total	6.33B	6.93B	7.31B	7.43B	8.47B
Operating Income	8.86B	5.07B	303M	5.7B	6.69B
Interest Expense, Total	-52M	-59M	-65M	-94M	-176M
Interest And Investment Income	190M	174M	321M	211M	268M
Net Interest Expenses	138M	115M	256M	117M	92M
Currency Exchange Gains (Loss)	532M	355M	664M	-248M	677M
Other Non Operating Income (Expenses)	-213M	-484M	35M	-144M	-125M
EBT, Excl. Unusual Items	9.32B	5.05B	1.26B	5.43B	7.33B
Gain (Loss) On Sale Of Investments	221M	258M	110M	61M	-20M
Gain (Loss) On Sale Of Assets	156M	-40M	18M	239M	815M
Asset Writedown	-297M	-45M	-36M	-126M	-464M
Legal Settlements	-18M	-15M	-20M	-31M	-7M
Other Unusual Items	17M	-4M	-2.13B	-6M	-6M
EBT, Incl. Unusual Items	9.39B	5.21B	-801M	5.56B	7.65B
Income Tax Expense	3.21B	2.11B	1.04B	1.6B	2.88B
Earnings From Continuing Operations	6.18B	3.1B	-1.84B	3.97B	4.77B
Net Income to Company	6.18B	3.1B	-1.84B	3.97B	4.77B
Minority Interest	-196M	-184M	-236M	-276M	-209M
Net Income - (IS)	5.99B	2.91B	-2.07B	3.69B	4.56B
Net Income to Common Incl Extra Items	5.99B	2.91B	-2.07B	3.69B	4.56B
Net Income to Common Excl. Extra Items	5.99B	2.91B	-2.07B	3.69B	4.56B
Per Share Items
Net EPS - Basic	69.25	33.1	-23.54	40.98	51.64
Basic EPS - Continuing Operations	69.25	33.1	-23.54	40.98	51.64
Basic Weighted Average Shares Outstanding	86.46M	88.04M	88.02M	90.07M	88.24M
Net EPS - Diluted	65.27	32.71	-23.54	40.98	51.57
Diluted EPS - Continuing Operations	65.27	32.71	-23.54	40.98	51.57
Diluted Weighted Average Shares Outstanding	91.72M	89.11M	88.02M	90.31M	88.37M
Normalized Basic EPS	65.07	33.78	6.25	34.6	49.56
Normalized Diluted EPS	61.33	33.37	6.25	34.51	49.49
Dividend Per Share	-	46	5.4	147	-
Payout Ratio	33.32	146.05	-196.48	13.06	57.34
Supplemental Items
EBITDA	10.29B	6.07B	1.13B	6.75B	7.58B
EBITA	8.86B	5.07B	303M	5.7B	6.69B
EBIT	8.86B	5.07B	303M	5.7B	6.69B
Effective Tax Rate - (Ratio)	34.18	40.49	-129.21	28.72	37.69
Normalized Net Income	5.63B	2.97B	550M	3.12B	4.37B
Non-Cash Pension Expense	104M	104M	20M	39M	187M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	183M	213M	250M	330M	459M

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	19.78B	28.07B	17.53B	21.67B	24.81B
Total Cash And Short Term Investments	19.78B	28.07B	17.53B	21.67B	24.81B
Accounts Receivable, Total	101B	99.33B	104B	88.78B	90.49B
Other Receivables	525M	51M	538M	-	2.56B
Notes Receivable	2M	2M	2M	29M	5M
Total Receivables	102B	99.38B	104B	88.81B	93.06B
Inventory	2.3B	2.22B	1.26B	1.31B	1.33B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	16.37B	12.31B	11.76B	8.27B	4.52B
Total Current Assets	140B	142B	135B	120B	124B
Net Property Plant And Equipment	17.15B	17.33B	17.7B	16.84B	15.11B
Long-term Investments	8.56B	8.99B	11.73B	12.16B	14.76B
Other Intangibles, Total	231M	601M	603M	510M	871M
Loans Receivable Long-Term	2.66B	406M	-	-	1.19B
Deferred Tax Assets Long-Term	850M	1.04B	274M	262M	259M
Other Long-Term Assets, Total	1M	1M	2M	2M	2M
Total Assets	170B	170B	165B	150B	156B
Liabilities
Accounts Payable, Total	45.4B	45.25B	44.68B	30.89B	30.93B
Accrued Expenses, Total	821M	808M	810M	678M	784M
Short-term Borrowings	2.95B	950M	6.95B	850M	2.35B
Current Portion of Long-Term Debt	3.15B	-	-	18M	-
Current Income Taxes Payable	558M	4.49B	866M	3.01B	2.62B
Unearned Revenue Current, Total	9.96B	9.32B	5.14B	8.47B	5.7B
Other Current Liabilities	23.61B	23B	24.31B	19.94B	22.16B
Total Current Liabilities	86.44B	83.83B	82.76B	63.86B	64.55B
Long-Term Debt	1.46B	6.03B	6.02B	6B	6B
Pension & Other Post Retirement Benefits	6.27B	6.34B	6.47B	5.6B	5.98B
Deferred Tax Liability Non Current	8M	-	9M	465M	1.29B
Other Non Current Liabilities	947M	993M	902M	849M	859M
Total Liabilities	95.13B	97.18B	96.16B	76.78B	78.68B
Common Stock, Total	10.55B	30.74B	10B	10B	10B
Additional Paid In Capital	9.06B	21.75B	42.45B	42.38B	42.33B
Retained Earnings	56.75B	20.84B	14.7B	17.91B	19.86B
Treasury Stock	-3.72B	-1.96B	-2.12B	-1.95B	-1.83B
Comprehensive Income and Other	1.01B	785M	2.63B	3.2B	5.14B
Total Common Equity	73.65B	72.15B	67.66B	71.54B	75.49B
Minority Interest	845M	1.03B	1.26B	1.53B	1.73B
Total Equity	74.49B	73.18B	68.92B	73.06B	77.22B
Total Liabilities And Equity	170B	170B	165B	150B	156B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	87.26M	88.15M	87.97M	81.6M	88.32M
ECS Total Common Shares Outstanding	-	88.15M	87.96M	88.17M	-
Book Value / Share	843.95	818.54	769.18	811.36	854.82
Tangible Book Value	73.42B	71.55B	67.06B	71.03B	74.62B
Tangible Book Value Per Share	841.31	811.72	762.33	805.58	844.96
Total Debt	7.56B	6.98B	12.97B	6.87B	8.35B
Net Debt	-12.22B	-21.1B	-4.56B	-14.8B	-16.46B
Debt Equivalent of Unfunded Proj. Benefit Obligation	6.27B	6.3B	6.43B	5.55B	5.91B
Minority Interest, Total (Incl. Fin. Div)	845M	1.03B	1.26B	1.53B	1.73B
Inventories - Raw Materials, Total	100M	85M	69M	80M	-
Inventories - Work In Process, Total	2.2B	2.14B	1.19B	1.23B	1.33B
Full Time Employees	1.69K	1.69K	1.69K	1.69K	1.7K
Accumulated Allowance for Doubtful Accounts (Supple)	6M	5M	2.12B	6M	109M
Order Backlog	225B	232B	210B	217B	-

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	9.4B	5.21B	-799M	5.56B	7.65B
Depreciation & Amortization - CF	1.43B	1.01B	831M	1.05B	894M
Depreciation & Amortization, Total	1.43B	1.01B	831M	1.05B	894M
(Gain) Loss From Sale Of Asset	141M	85M	18M	-113M	-350M
(Gain) Loss on Sale of Investments - (CF)	-221M	-259M	-101M	-55M	15M
Other Operating Activities, Total	-4.87B	-528M	-3.15B	-181M	-1.25B
Change In Accounts Receivable	-10.12B	1.86B	-6.47B	17.01B	-1.81B
Change In Inventories	781M	151M	967M	-48M	-10M
Change In Accounts Payable	1.14B	-152M	-418M	-13.79B	183M
Change in Other Net Operating Assets	7.86B	5.49B	-2.42B	2.34B	-1.44B
Cash from Operations	5.54B	12.86B	-11.54B	11.78B	3.89B
Capital Expenditure	-2.07B	-1.04B	-1.58B	-451M	-355M
Sale of Property, Plant, and Equipment	598M	33M	223M	498M	1.61B
Sale (Purchase) of Intangible assets	-100M	-287M	-188M	-157M	-526M
Investment in Marketable and Equity Securities, Total	-198M	-242M	184M	-738M	585M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-422M	2.28B	413M	-21M	-1.16B
Other Investing Activities, Total	-	14M	-49M	-7M	-3M
Cash from Investing	-2.19B	758M	-996M	-876M	153M
Short Term Debt Issued, Total	-	-	6B	-	1.5B
Long-Term Debt Issued, Total	-	5.88B	-	-	-
Total Debt Issued	-	5.88B	6B	-	1.5B
Short Term Debt Repaid, Total	-5B	-2B	-	-6.1B	-
Long-Term Debt Repaid, Total	-	-3.15B	-	-	-7M
Total Debt Repaid	-5B	-5.15B	-	-6.1B	-7M
Issuance of Common Stock	-	40.19B	-	-	-
Repurchase of Common Stock	-4.77B	-42.02B	-213M	-5M	-
Common Dividends Paid	-2B	-4.26B	-4.07B	-482M	-2.61B
Common & Preferred Stock Dividends Paid	-2B	-4.26B	-4.07B	-482M	-2.61B
Other Financing Activities, Total	-207M	-76M	9M	-34M	-40M
Cash from Financing	-11.97B	-5.43B	1.72B	-6.62B	-1.16B
Foreign Exchange Rate Adjustments	176M	90M	307M	-145M	244M
Miscellaneous Cash Flow Adjustments	1M	-	-1M	-	1M
Net Change in Cash	-8.45B	8.27B	-10.5B	4.13B	3.13B
Supplemental Items
Cash Interest Paid	52M	61M	63M	96M	174M
Cash Income Tax Paid (Refund)	4.86B	530M	3.14B	162M	1.24B
Levered Free Cash Flow	2.17B	11.82B	-11.17B	9.96B	2.78B
Unlevered Free Cash Flow	2.2B	11.85B	-11.13B	10.02B	2.89B
Change In Net Working Capital	2.6B	-9B	10.38B	-6.02B	1.3B
Net Debt Issued / Repaid	-5B	728M	6B	-6.1B	1.49B

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	3.25	1.86	0.11	2.26	2.73
Return on Total Capital	6.49	3.9	0.23	4.41	5.05
Return On Equity %	8.32	4.2	-2.58	5.59	6.34
Return on Common Equity	8.14	4	-2.96	5.3	6.2
Margin Analysis
Gross Profit Margin %	9.71	7.69	4.66	9.16	10.84
SG&A Margin	4.04	4.44	4.38	5.29	5.89
EBITDA Margin %	6.57	3.89	0.69	4.71	5.42
EBITA Margin %	5.66	3.25	0.19	3.98	4.78
EBIT Margin %	5.66	3.25	0.19	3.98	4.78
Income From Continuing Operations Margin %	3.95	1.99	-1.12	2.77	3.41
Net Income Margin %	3.82	1.87	-1.27	2.57	3.26
Net Avail. For Common Margin %	3.82	1.87	-1.27	2.57	3.26
Normalized Net Income Margin	3.59	1.91	0.34	2.17	3.13
Levered Free Cash Flow Margin	1.39	7.57	-6.84	6.94	1.99
Unlevered Free Cash Flow Margin	1.41	7.6	-6.82	6.99	2.06
Asset Turnover
Asset Turnover	0.92	0.92	0.97	0.91	0.91
Fixed Assets Turnover	9.12	9.05	9.32	8.3	8.75
Receivables Turnover (Average Receivables)	1.63	1.56	1.61	1.49	1.56
Inventory Turnover (Average Inventory)	52.51	63.68	89.46	101.37	94.44
Short Term Liquidity
Current Ratio	1.62	1.69	1.63	1.88	1.92
Quick Ratio	1.41	1.52	1.47	1.73	1.83
Operating Cash Flow to Current Liabilities	0.06	0.15	-0.14	0.18	0.06
Days Sales Outstanding (Average Receivables)	224.16	234.5	227.6	244.95	234
Days Outstanding Inventory (Average Inventory)	6.95	5.73	4.09	3.6	3.86
Average Days Payable Outstanding	116.42	114.91	106.42	105.84	90.5
Cash Conversion Cycle (Average Days)	114.7	125.32	125.28	142.71	147.36
Long Term Solvency
Total Debt/Equity	10.15	9.53	18.82	9.4	10.81
Total Debt / Total Capital	9.22	8.7	15.84	8.59	9.76
LT Debt/Equity	1.96	8.23	8.74	8.21	7.77
Long-Term Debt / Total Capital	1.78	7.52	7.35	7.51	7.01
Total Liabilities / Total Assets	56.08	57.05	58.25	51.24	50.47
EBIT / Interest Expense	170.35	85.86	4.66	60.67	37.99
EBITDA / Interest Expense	197.88	102.93	17.45	71.8	43.07
(EBITDA - Capex) / Interest Expense	158.04	85.34	-6.85	67	41.06
Total Debt / EBITDA	0.73	1.15	11.44	1.02	1.1
Net Debt / EBITDA	-1.19	-3.47	-4.02	-2.19	-2.17
Total Debt / (EBITDA - Capex)	0.92	1.39	-29.15	1.09	1.16
Net Debt / (EBITDA - Capex)	-1.49	-4.19	10.25	-2.35	-2.28
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-3.2	-0.3	4.6	-12.15	-2.49
Gross Profit, 1 Yr. Growth %	0.62	-21.04	-36.55	72.59	15.41
EBITDA, 1 Yr. Growth %	1.84	-40.98	-81.33	495.15	12.33
EBITA, 1 Yr. Growth %	-2.29	-42.81	-94.02	1.78K	17.25
EBIT, 1 Yr. Growth %	-2.29	-42.81	-94.02	1.78K	17.25
Earnings From Cont. Operations, 1 Yr. Growth %	-3.15	-49.89	-159.26	-316.07	20.14
Net Income, 1 Yr. Growth %	-4.39	-51.33	-171.1	-278.14	23.46
Normalized Net Income, 1 Yr. Growth %	-2.42	-47.15	-81.49	466.38	40.31
Diluted EPS Before Extra, 1 Yr. Growth %	0.03	-49.89	-171.97	-274.09	25.84
Accounts Receivable, 1 Yr. Growth %	11.11	-1.83	4.38	-14.37	1.92
Inventory, 1 Yr. Growth %	-25.23	-3.56	-43.36	4.29	1.22
Net Property, Plant and Equip., 1 Yr. Growth %	-0.19	1.06	2.15	-4.87	-10.3
Total Assets, 1 Yr. Growth %	-0.75	0.44	-3.1	-9.23	4.04
Tangible Book Value, 1 Yr. Growth %	0.17	-2.54	-6.28	5.92	5.06
Common Equity, 1 Yr. Growth %	0.23	-2.03	-6.23	5.73	5.53
Cash From Operations, 1 Yr. Growth %	-227.08	132.18	-189.73	-202.08	-66.98
Capital Expenditures, 1 Yr. Growth %	-71.5	-49.9	52.12	-71.44	-21.29
Levered Free Cash Flow, 1 Yr. Growth %	-116.67	444.8	-194.52	-189.17	-72.11
Unlevered Free Cash Flow, 1 Yr. Growth %	-116.97	438.43	-193.89	-190.02	-71.18
Dividend Per Share, 1 Yr. Growth %	-	-	-88.26	2.62K	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-1.95	-1.76	2.12	-4.14	-7.45
Gross Profit, 2 Yr. CAGR %	2.6	-10.86	-29.22	4.65	41.13
EBITDA, 2 Yr. CAGR %	5.57	-22.47	-66.8	5.42	158.56
EBITA, 2 Yr. CAGR %	1.72	-25.25	-81.51	6.1	369.78
EBIT, 2 Yr. CAGR %	1.72	-25.25	-81.51	6.1	369.78
Earnings From Cont. Operations, 2 Yr. CAGR %	-4.25	-30.34	-45.51	13.16	61.12
Net Income, 2 Yr. CAGR %	-5.09	-31.78	-41.17	12.55	48.3
Normalized Net Income, 2 Yr. CAGR %	3.38	-28.18	-68.73	2.38	181.91
Diluted EPS Before Extra, 2 Yr. CAGR %	-8.76	-29.2	-39.95	11.94	48.02
Accounts Receivable, 2 Yr. CAGR %	11.33	4.44	1.22	-5.46	-6.58
Inventory, 2 Yr. CAGR %	-29.2	-15.08	-26.09	-23.14	2.74
Net Property, Plant and Equip., 2 Yr. CAGR %	23.86	0.43	1.6	-1.42	-7.62
Total Assets, 2 Yr. CAGR %	5.57	-0.16	-1.35	-6.21	-2.82
Tangible Book Value, 2 Yr. CAGR %	6.82	-1.19	-4.43	-0.37	5.49
Common Equity, 2 Yr. CAGR %	6.89	-0.91	-4.15	-0.43	5.63
Cash From Operations, 2 Yr. CAGR %	2.55	71.77	44.34	-4.29	-41.95
Capital Expenditures, 2 Yr. CAGR %	23.93	-62.21	-12.7	-34.08	-52.58
Levered Free Cash Flow, 2 Yr. CAGR %	-44.77	-4.7	126.93	-8.19	-50.13
Unlevered Free Cash Flow, 2 Yr. CAGR %	-44.27	-4.4	124.84	-8.07	-49.06
Dividend Per Share, 2 Yr. CAGR %	-	44.6	-	78.76	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.25	-1.4	0.31	-2.88	-3.6
Gross Profit, 3 Yr. CAGR %	0.81	-5.98	-20.41	-4.73	8.12
EBITDA, 3 Yr. CAGR %	1.46	-13.03	-51.76	-13.12	7.67
EBITA, 3 Yr. CAGR %	-1.14	-16.04	-67.79	-13.65	9.7
EBIT, 3 Yr. CAGR %	-1.14	-16.04	-67.79	-13.65	9.7
Earnings From Cont. Operations, 3 Yr. CAGR %	-0.13	-22.84	-33.99	-13.75	15.44
Net Income, 3 Yr. CAGR %	-0.84	-24.03	-30.83	-14.89	16.07
Normalized Net Income, 3 Yr. CAGR %	-0.31	-17.33	-54.3	-17.87	13.72
Diluted EPS Before Extra, 3 Yr. CAGR %	-2.57	-25.28	-28.81	-14.37	16.39
Accounts Receivable, 3 Yr. CAGR %	12.65	6.75	4.42	-4.26	-3.06
Inventory, 3 Yr. CAGR %	-5.66	-21.52	-25.8	-17.1	-15.75
Net Property, Plant and Equip., 3 Yr. CAGR %	14.55	15.74	1	-0.6	-4.47
Total Assets, 3 Yr. CAGR %	4.9	3.83	-1.15	-4.05	-2.91
Tangible Book Value, 3 Yr. CAGR %	6.22	3.6	-2.92	-1.1	1.41
Common Equity, 3 Yr. CAGR %	6.26	3.83	-2.71	-0.96	1.52
Cash From Operations, 3 Yr. CAGR %	176.83	34.66	38.34	28.6	-32.88
Capital Expenditures, 3 Yr. CAGR %	-1.98	-8.36	-39.89	-39.85	-30.07
Levered Free Cash Flow, 3 Yr. CAGR %	36.07	18.45	-4.96	66.21	-38.28
Unlevered Free Cash Flow, 3 Yr. CAGR %	37.89	18.7	-4.97	65.71	-37.54
Dividend Per Share, 3 Yr. CAGR %	-	32	-37.39	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.74	0.84	1.6	-2.51	-2.87
Gross Profit, 5 Yr. CAGR %	-0.03	-6.04	-12.48	-1.86	0.08
EBITDA, 5 Yr. CAGR %	-0.38	-12.33	-35.1	-6.07	-5.58
EBITA, 5 Yr. CAGR %	-2.49	-14.72	-49.44	-7.8	-5.91
EBIT, 5 Yr. CAGR %	-2.49	-14.72	-49.44	-7.8	-5.91
Earnings From Cont. Operations, 5 Yr. CAGR %	-2.63	-17.11	-21.62	-10.07	-5.68
Net Income, 5 Yr. CAGR %	-3.18	-18.05	-19.53	-11.1	-6.16
Normalized Net Income, 5 Yr. CAGR %	-2.25	-15.72	-37.3	-9.95	-5.38
Diluted EPS Before Extra, 5 Yr. CAGR %	-4.17	-18.34	-19.71	-12.17	-4.6
Accounts Receivable, 5 Yr. CAGR %	8.55	8.54	7.93	1.69	-0.13
Inventory, 5 Yr. CAGR %	1.63	-1.32	-14.44	-22.17	-15.49
Net Property, Plant and Equip., 5 Yr. CAGR %	14.68	11.92	9.18	8.54	-2.54
Total Assets, 5 Yr. CAGR %	5.59	3.84	2.36	-0.31	-1.82
Tangible Book Value, 5 Yr. CAGR %	8.2	4.51	1.82	2	0.36
Common Equity, 5 Yr. CAGR %	8.21	4.63	1.96	2.11	0.54
Cash From Operations, 5 Yr. CAGR %	21.84	-3.05	113.35	17.47	-2.25
Capital Expenditures, 5 Yr. CAGR %	9.77	-11.19	-6.42	-19.68	-45.33
Levered Free Cash Flow, 5 Yr. CAGR %	73.9	-0.96	66.96	6.97	-26.57
Unlevered Free Cash Flow, 5 Yr. CAGR %	81.42	-0.93	67.67	7.17	-25.95
Dividend Per Share, 5 Yr. CAGR %	-	25.12	-18.48	49.02	-